Dr. Josh Sasine is a hematologist and oncologist at UCLA specializing in the treatment of hematologic malignancies, including hematopoietic stem cell transplantation (bone marrow transplantation), cellular therapy, and clinical trials of novel therapeutics. He is the Director of the Chimeric Antigen Receptor T-Cell (CAR T) Program. He treats patients with blood and bone marrow disorders such as leukemia, myelodysplastic syndrome, lymphoma, multiple myeloma, amyloidosis, aplastic anemia, Waldenstrom Macroglobulinemia, polycythemia vera, primary myelofibrosis, paroxysmal nocturnal hemoglobinuria (PNH), and others. Dr. Sasine is a physician-scientist and has an active scientific research program studying how cancer cells in the bone marrow get by supported by their non-cancerous neighboring cells; the goal of the work is to discover new medicines by inhibiting these interactions.
Chimeric Antigen Receptor T-Cell (CAR-T) Program
How Immunotherapy Became the Next Big Thing UCLA Health - U MagazineNew immunotherapy program offers new hope to patients with certain blood cancers UCLA Health - UNews UCLA establishes CAR T-cell therapy program UCLA Health - Clinical Updates
2018 CTSI KL2 Translational Science Award 2017 Tower Cancer Research Foundation Career Development Award 2017 American Society of Clinical Oncology and Conquer Cancer Young Investigator Award 2017 Chief Fellow, UCLA STAR Program 2017 UCLA Department of Medicine, Specialty Training and Advanced Research Innovator Award 2015 Eli & Edythe Broad Center of Regenerative Medicine & Stem Cell Research at UCLA Clinical Fellow Training Program Award 2013 American Board of Internal Medicine Research Pathway Designation 2012 UCLA Commendations for Excellence in Medical Student Teaching Award